Skip to Main Content

An official website of the United States government

Principal Investigator
Name
Jessica Petrick
Degrees
PhD
Institution
Boston University
Position Title
Investigator
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
2018-0014
Initial CDAS Request Approval
Jun 29, 2018
Title
What are the mechanisms of obesity on the premalignant lesion of esophageal adenocarcinoma? The relevance of the oral myco- and microbiome in Barrett’s esophagus.
Summary
Barrett’s esophagus is a pre-neoplastic metaplasia of esophageal adenocarcinoma and its only known precursor. Abdominal obesity is one of the main risk factors for Barrett’s esophagus, but the mechanisms that underlie the relationship between obesity and risk of Barrett’s esophagus remain incompletely understood. Although many assume a direct, mechanical effect of obesity on promoting gastroesophageal reflux leading to oxidative damage and replacement with Barrett’s metaplasia, the evidence is not conclusive to such a hypothesis. Thus, innovative, alternative hypotheses merit investigation. We hypothesize that the oral microbiota—the community of microorganisms, including fungi and bacteria, that reside within human tissues and biofluids—interacts with obesity to influence risk of Barrett’s esophagus. Studying premalignant lesions, such as Barrett’s esophagus, can elucidate key risk factors that act early in disease onset. The proposed study will leverage cutting-edge technologies and statistical techniques combined with existing oral rinse samples to investigate this hypothesis and potentially provide evidence in support of a new paradigm of how obesity affects risk of Barrett’s esophagus.
Aims

1. To evaluate the association between the myco- and microbiome and the premalignant lesion of esophageal adenocarcinoma – Barrett’s esophagus.
a. To evaluate the interaction between obesity and the myco/microbiome on risk of Barrett’s esophagus.
b. To evaluate the extent that association between obesity and Barrett’s esophagus is mediated by the myco/microbiome.

Collaborators

Jessica Petrick (Boston University)
Mitchell Gail (National Cancer Institute)
Yunhu Wan (National Cancer Institute)
Michael B. Cook (National Cancer Institute)
Christian C. Abnet (National Cancer Institute)
Linda M. Liao (National Cancer Institute)
Emily Vogtmann (National Cancer Institute)